Financial reports
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
10-K
2022 FY
Annual report
9 Mar 23
NT 10-K
Notice of late annual filing
2 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
Current reports
8-K
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial
24 Apr 24
8-K
Departure of Directors or Certain Officers
24 Apr 24
8-K
Supernus Provides Regulatory Update for SPN-830
8 Apr 24
8-K
Departure of Directors or Certain Officers
28 Feb 24
8-K
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
27 Feb 24
8-K
Departure of Directors or Certain Officers
20 Feb 24
8-K
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial
13 Feb 24
8-K
Other Events
5 Feb 24
8-K
Supernus Announces Third Quarter 2023 Financial Results
8 Nov 23
8-K
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
2 Nov 23
Registration and prospectus
SC TO-T/A
Third party tender offer statement (amended)
24 Nov 21
SC TO-T/A
Third party tender offer statement (amended)
23 Nov 21
SC TO-T
Third party tender offer statement
25 Oct 21
SC TO-C
Information about tender offer
12 Oct 21
S-8
Registration of securities for employees
25 Jun 21
S-8
Registration of securities for employees
26 Jun 20
S-8
Registration of securities for employees
17 Feb 17
S-8
Registration of securities for employees
18 Dec 14
S-3
Shelf registration
4 Dec 14
424B4
Prospectus supplement with pricing info
30 Nov 12
Proxies
DEFA14A
Additional proxy soliciting materials
1 May 23
DEF 14A
Definitive proxy
1 May 23
DEFA14A
Additional proxy soliciting materials
2 May 22
DEF 14A
Definitive proxy
2 May 22
DEFA14A
Additional proxy soliciting materials
24 May 21
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEF 14A
Definitive proxy
30 Apr 21
DEFA14A
Additional proxy soliciting materials
4 May 20
DEFA14A
Additional proxy soliciting materials
24 Apr 20
DEF 14A
Definitive proxy
24 Apr 20
Other
UPLOAD
Letter from SEC
7 Aug 19
CORRESP
Correspondence with SEC
31 Jul 19
UPLOAD
Letter from SEC
17 Jul 19
UPLOAD
Letter from SEC
7 Dec 18
CT ORDER
Confidential treatment order
30 Nov 18
CORRESP
Correspondence with SEC
16 Nov 18
UPLOAD
Letter from SEC
2 Nov 18
CORRESP
Correspondence with SEC
5 Oct 18
UPLOAD
Letter from SEC
21 Sep 18
UPLOAD
Letter from SEC
18 Oct 17
Ownership
4
Padmanabh P. Bhatt
25 Mar 24
4
Padmanabh P. Bhatt
22 Mar 24
4
Padmanabh P. Bhatt
21 Mar 24
144
Notice of proposed sale of securities
19 Mar 24
4
Padmanabh P. Bhatt
15 Mar 24
4
Padmanabh P. Bhatt
14 Mar 24
144
Notice of proposed sale of securities
13 Mar 24
144
Notice of proposed sale of securities
12 Mar 24
4
Frank Mottola
29 Feb 24
4
Jack A. Khattar
29 Feb 24